본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Pharmacology & therapeutics v.181, 2018년, pp.156 - 168   SCI SCIE
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy

Bianconi, Vanessa (Unit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy ) ; Sahebkar, Amirhossein (Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran ) ; Kovanen, Petri (Wihuri Research Institute, Helsinki, Finland ) ; Bagaglia, Francesco (Unit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy ) ; Ricciuti, Biagio (Department of Medical Oncology, S. Maria della Misericordia Hospital, Perugia, Italy ) ; Calabrò, Paolo (Division of Cardiology, Second University of Naples, Department of Cardio-Thoracic and Respiratory Sciences, Italy ) ; Patti, Giuseppe (Unit of Cardiovascular Science, Campus Bio-Medico University of Rome, Italy ) ; Pirro, Matteo (Unit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy ) ;
  • 초록  

    Abstract Stem cells have the potential to differentiate into cardiovascular cell lineages and to stimulate tissue regeneration in a paracrine/autocrine manner; thus, they have been extensively studied as candidate cell sources for cardiovascular regeneration. Several preclinical and clinical studies addressing the therapeutic potential of endothelial progenitor cells (EPCs) and cardiac progenitor cells (CPCs) in cardiovascular diseases have been performed. For instance, autologous EPC transplantation and EPC mobilization through pharmacological agents contributed to vascular repair and neovascularization in different animal models of limb ischemia and myocardial infarction. Also, CPC administration and in situ stimulation of resident CPCs have been shown to improve myocardial survival and function in experimental models of ischemic heart disease. However, clinical studies using EPC- and CPC-based therapeutic approaches have produced mixed results. In this regard, intracoronary, intra-myocardial or intramuscular injection of either bone marrow-derived or peripheral blood progenitor cells has improved pathological features of tissue ischemia in humans, despite modest or no clinical benefit has been observed in most cases. Also, the intriguing scientific background surrounding the potential clinical applications of EPC capture stenting is still waiting for a confirmatory proof. Moreover, clinical findings on the efficacy of CPC-based cell therapy in heart diseases are still very preliminary and based on small-size studies. Despite promising evidence, widespread clinical application of both EPCs and CPCs remains delayed due to several unresolved issues. The present review provides a summary of the different applications of EPCs and CPCs for cardiovascular cell therapy and underlies their advantages and limitations.


  • 주제어

    Endothelial progenitor cells .   Stem cells .   EPC .   CPC .   Myocardial infarction .   Regenerative medicine.  

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기